3 studies found for:    11857671 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions
Conditions: Neurogenic Urinary Bladder;   Neurogenic Bladder Disorder;   Neurogenic Dysfunction of the Urinary Bladder;   Neurogenic Bladder, Uninhibited;   Neurogenic Bladder, Spastic
Interventions: Drug: SAF312;   Drug: Placebo to SAF312
2 Completed
Has Results
Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1
Condition: Bladder Outlet Obstruction
Interventions: Drug: Detrusitol 4 mg QD;   Drug: Doxazosin 4 mg QD
3 Recruiting Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment
Condition: Interstitial Cystitis
Interventions: Drug: Botulinum toxin A;   Drug: Normal saline instillation

Indicates status has not been verified in more than two years